Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014 (2014), Article ID 287381, 9 pages
http://dx.doi.org/10.1155/2014/287381
Research Article

Astrocyte Elevated Gene-1 Mediates Glycolysis and Tumorigenesis in Colorectal Carcinoma Cells via AMPK Signaling

1Department of Pathology, The Affiliated Tumor Hospital of Harbin Medical University, Harbin 150040, China
2Department of Medical Genetics, Harbin Medical University, Harbin 150086, China

Received 8 December 2013; Revised 17 February 2014; Accepted 19 March 2014; Published 16 April 2014

Academic Editor: Antonio Macciò

Copyright © 2014 Hong-tao Song et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Degenhardt, R. Mathew, B. Beaudoin et al., “Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis,” Cancer Cell, vol. 10, no. 1, pp. 51–64, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. H. Wilting and J.-H. Dannenberg, “Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance,” Drug Resistance Updates, vol. 15, no. 1-2, pp. 21–38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. C.-P. Kung, A. Budina, G. Balaburski, M. K. Bergenstock, and M. E. Murphy, “Autophagy in tumor suppression and cancer therapy,” Critical Reviews in Eukaryotic Gene Expression, vol. 21, no. 1, pp. 71–100, 2011. View at Google Scholar · View at Scopus
  4. S. Y. Lunt and M. G. Vander Heiden, “Aerobic glycolysis: meeting the metabolic requirements of cell proliferation,” Annual Review of Cell and Developmental Biology, vol. 27, pp. 441–464, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. T. M. Morgan, T. D. Koreckij, and E. Corey, “Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway,” Current Cancer Drug Targets, vol. 9, no. 2, pp. 237–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. S.-M. Maira, P. Furet, and F. Stauffer, “Discovery of novel anticancer therapeutics targeting the PI3K/Akt/mTOR pathway,” Future Medicinal Chemistry, vol. 1, no. 1, pp. 137–155, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Emdad, S.-G. Lee, Z. Z. Su et al., “Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 50, pp. 21300–21305, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. Ying, J. Li, and M. Li, “Astrocyte elevated gene 1: biological functions and molecular mechanism in cancer and beyond,” Cell & Bioscience, vol. 1, no. 1, p. 36, 2011. View at Google Scholar
  9. S.-G. Lee, Z.-Z. Su, L. Emdad, D. Sarkar, T. F. Franke, and P. B. Fisher, “Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling,” Oncogene, vol. 27, no. 8, pp. 1114–1121, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S.-G. Lee, Z.-Z. Su, L. Emdad, D. Sarkar, and P. B. Fisher, “Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring-phosphatidylinositol 3-kinase and c-Myc,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 46, pp. 17390–17395, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. S.-G. Lee, H.-Y. Jeon, Z.-Z. Su et al., “Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma,” Oncogene, vol. 28, no. 26, pp. 2476–2484, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Wang, Z.-F. Ke, S.-J. Sun et al., “Oncogenic roles of astrocyte elevated gene-1 (AEG-1) in osteosarcoma progression and prognosis,” Cancer Biology and Therapy, vol. 12, no. 6, pp. 539–548, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. S. K. Bhutia, T. P. Kegelman, S. K. Das et al., “Astrocyte elevated gene-1 induces protective autophagy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 51, pp. 22243–22248, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Y. Byoung, L. Emdad, Z.-Z. Su et al., “Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression,” Journal of Clinical Investigation, vol. 119, no. 3, pp. 465–477, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Brachmann, C. Fritsch, S.-M. Maira, and C. García-Echeverría, “PI3K and mTOR inhibitors—a new generation of targeted anticancer agents,” Current Opinion in Cell Biology, vol. 21, no. 2, pp. 194–198, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. B. K. Yoo, L. Emdad, S.-G. Lee et al., “Astrocyte elevated gene-1 (AEG-1): a multifunctional regulator of normal and abnormal physiology,” Pharmacology and Therapeutics, vol. 130, no. 1, pp. 1–8, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Noch, M. Bookland, and K. Khalili, “Astrocyte-elevated gene-1 (AEG-1) induction by hypoxia and glucose deprivation in glioblastoma,” Cancer Biology and Therapy, vol. 11, no. 1, pp. 32–39, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Lee, D. Jung, E. Sohn et al., “Inhibition of hypoxia inducible factor alpha and astrocyte-elevated gene-1 mediates cryptotanshinone exerted antitumor activity in hypoxic PC-3 cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 390957, 13 pages, 2012. View at Publisher · View at Google Scholar
  19. S. K. Bhutia, T. P. Kegelman, S. K. Das et al., “Astrocyte elevated gene-1 activates AMPK in response to cellular metabolic stress and promotes protective autophagy,” Autophagy, vol. 7, no. 5, pp. 547–548, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. D. A. Fruman and A. L. Edinger, “Cancer therapy: staying current with AMPK,” The Biochemical journal, vol. 412, no. 2, pp. e3–e5, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Fogarty and D. G. Hardie, “Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer,” Biochimica et Biophysica Acta, vol. 1804, no. 3, pp. 581–591, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Luo, M. Zang, and W. Guo, “AMPK as a metabolic tumor suppressor: control of metabolism and cell growth,” Future Oncology, vol. 6, no. 3, pp. 457–470, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Vazquez-Martin, C. Oliveras-Ferraros, E. Lopez-Bonet, and J. A. Menendez, “AMPK: evidence for an energy-sensing cytokinetic tumor suppressor,” Cell Cycle, vol. 8, no. 22, pp. 3679–3683, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Song, C. Li, R. Lu, Y. Zhang, and J. Geng, “Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer,” International Journal of Gynecological Cancer, vol. 20, no. 7, pp. 1188–1196, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Ke, X. Mao, C. Zeng et al., “AEG-1 expression characteristics in human non-small cell lung cancer and its relationship with apoptosis,” Medical Oncology, vol. 30, no. 1, p. 383, 2013. View at Google Scholar
  26. L. Vucicevic, M. Misirkic, K. Janjetovic et al., “Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway,” Autophagy, vol. 7, no. 1, pp. 40–50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Pavlides, I. Vera, R. Gandara et al., “Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis,” Antioxidants and Redox Signaling, vol. 16, no. 11, pp. 1264–1284, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. D.-C. Kang, Z.-Z. Su, D. Sarkar, L. Emdad, D. J. Volsky, and P. B. Fisher, “Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1,” Gene, vol. 353, no. 1, pp. 8–15, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Hu, R. A. Chong, Q. Yang et al., “MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer,” Cancer Cell, vol. 15, no. 1, pp. 9–20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Kikuno, H. Shiina, S. Urakami et al., “Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity,” Oncogene, vol. 26, no. 55, pp. 7647–7655, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Yu, K. Chen, H. Zheng et al., “Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis,” Carcinogenesis, vol. 30, no. 5, pp. 894–901, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Buerkle and W. A. Weber, “Imaging of tumor glucose utilization with positron emission tomography,” Cancer and Metastasis Reviews, vol. 27, no. 4, pp. 545–554, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Zhu, D. Lee, and H. Shim, “Metabolic positron emission tomography imaging in cancer detection and therapy response,” Seminars in Oncology, vol. 38, no. 1, pp. 55–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Pelicano, D. S. Martin, R.-H. Xu, and P. Huang, “Glycolysis inhibition for anticancer treatment,” Oncogene, vol. 25, no. 34, pp. 4633–4646, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. D. A. Tennant, R. V. Durán, and E. Gottlieb, “Targeting metabolic transformation for cancer therapy,” Nature Reviews Cancer, vol. 10, no. 4, pp. 267–277, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Lu, X. Zhang, H. Zhang et al., “Citrate induces apoptotic cell death: a promising way to treat gastric carcinoma?” Anticancer Research, vol. 31, no. 3, pp. 797–805, 2011. View at Google Scholar · View at Scopus
  37. V. Gogvadze, “Targeting mitochondria in fighting cancer,” Current Pharmaceutical Design, vol. 17, no. 36, pp. 4034–4046, 2011. View at Google Scholar · View at Scopus
  38. H. Xiao, S. Li, D. Zhang et al., “Separate and concurrent use of 2-deoxy-D-glucose and 3-bromopyruvate in pancreatic cancer cells,” Oncology Reports, vol. 29, no. 1, pp. 329–334, 2013. View at Google Scholar